Number of antibiotic prescriptions in female and male patients with UTI (N30.0 and/or N39.0). by Thomas Hanslmeier (19949694)

Subjects: “…fluoroquinolone shares decreased…”

Shares of antibiotic substances on total prescription in female patients with UTI (N39.0, N30.0) by physician specialties (GPs: n = 1.299.641 prescriptions; gynecologists n = 141.8... by Thomas Hanslmeier (19949694)

Subjects: “…fluoroquinolone shares decreased…”

Comparison of 1^st, 2^nd, and 3^rd antibiotic prescription. by Thomas Hanslmeier (19949694)

Subjects: “…fluoroquinolone shares decreased…”

UTI diagnoses by sex and physician specialty (2013–2019). by Thomas Hanslmeier (19949694)

Subjects: “…fluoroquinolone shares decreased…”

Additional file 3 of Single-cell profiling reveals a reduced epithelial defense system, decreased immune responses and the immune regulatory roles of different fibroblast subpopula... by Lin Lin (46073)

“…P values were calculated via the two-sided Wilcoxon test. ns, not significant, **, P < 0.01 and ****, P < 0.0001. (G) Feature plot showing LDLR expression levels in C1Q+ macrophages between CAG and control samples.…”

LDH expression is a surrogate for cell death. by Bryan S. Margulies (21492667)

Subjects:

Diagrammatic illustration showing the time-course of the experimental set-up as well as the experimental endpoints. by Bryan S. Margulies (21492667)

Subjects:

Mice in the NTC and MBC-005 treatment groups were evaluated for bioluminescent signaling at 6-, 13-, and 21-days after tumor inoculation. by Bryan S. Margulies (21492667)

Subjects:

Echogenic properties were assessed using a portable ultrasound, similar to the devices that are used clinically. by Bryan S. Margulies (21492667)

Subjects:

MCF7 cultures were treated with either MBC-005 or doxorubicin. by Bryan S. Margulies (21492667)

Subjects:

Cox proportional hazard ratios. by Bryan S. Margulies (21492667)

Subjects:

Liver samples were stained with hematoxylin and eosin and imaged at 4x. by Bryan S. Margulies (21492667)

Subjects:

Bioluminescent Doubling Time. by Bryan S. Margulies (21492667)

Subjects:

Study Design. by Bryan S. Margulies (21492667)

Subjects:

Liver weights were normalized by the mouse body weight to derive the %liver weight. by Bryan S. Margulies (21492667)

Subjects:

Histomorphometric analysis of the tumor volume fraction (V_f) in the liver and necrosis volume fraction. by Bryan S. Margulies (21492667)

Subjects:

(A) Release rate (i.e., elution) of N-allyl noroxymorphone hydrochloride evaluated using UPLC from two samples of MBC-005. The equations predict that at 24-hours there will be betw... by Bryan S. Margulies (21492667)

Subjects:

The MTT assay and the LDH assay were used to assess the effects of the hydrogel component of MBC-005 on tumor cell number and cell death. by Bryan S. Margulies (21492667)

Subjects:

The spheroid assay is used to assess long-term effects of therapy on tumor cell by culturing the tumor cells in a micro-mass, which is a 3D tumor mass used as a surrogate for in vi... by Bryan S. Margulies (21492667)

Subjects:

Survival in mice with liver metastases after MBC-005 TREATMENT. by Bryan S. Margulies (21492667)

Subjects: